We're attending BIO China 2026 in Guangzhou, China, on 12–14 March 2026.

Bringing together global leaders in biotechnology, life sciences, and biopharmaceutical innovation, BIO China serves as a major platform for scientific exchange, strategic partnerships, and the advancement of cutting‑edge technologies shaping the future of healthcare.

Representing Richmond Pharmacology:

  • Stephen Wilkinson, Business Development Manager

Our Focus at the Exhibition

  • Emerging biotechnology platforms and therapeutic innovations
  • Global clinical development strategies and regulatory pathways
  • Strengthening cross‑border collaboration and partnering opportunities
  • Advances in early‑phase clinical trial design
  • Building sustainable scientific and commercial relationships in the Asia‑Pacific region

Connect With Us

If you are attending BIO China 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: BIOCHINA

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

Women's Health Horizons 2026

22 September 2026
Richmond Pharmacology is pleased to join the Women’s Health Horizons London Summit hosted by the Royal College of Obstetricians and Gynaecologists in London, 22 September 2026
View event